NDC11 72205014799
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 72205-0147-99 | 72205-0147 |
| 72205-147-99 | 72205-147 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| olmesartan medoxomil-hydrochlorothiazide | OLMESARTAN MEDOXOMIL-HYDROCHLOROTHIAZIDE | Novadoz Pharmaceuticals LLC | c8197eea-e990-4c0e-bc2d-f080bac8de17 | 2025-09-26 | Boxed warning, Warnings, Adverse reactions | 72205-147-99 72205-147 72205014799 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.